Risks tied to this specific entity.
No issues detected across 7 sources
No issues detected across 1 source
DSM-Firmenich's Firmenich subsidiary faces CCI investigation for alleged anti-poaching agreements with competitors, presenting regulatory and reputational risks.
NestlΓ© infant formula recall involving toxin contamination poses high reputational and supply chain risk to DSM-Firmenich as a key ingredient supplier to infant nutrition products.
DSM-Firmenich's announcement of 1,000 global job cuts and β¬100M cost-reduction program presents elevated supply chain risk through potential operational disruptions and capacity constraints.
DSM-Firmenich's β¬2.2 billion sale of its animal nutrition unit presents medium supply chain risk due to potential operational transitions and changes in product availability and service continuity.
DSM-Firmenich's sale of ANH business to CVC Capital Partners creates supply chain risk through business unit separation and operational restructuring.
DSM-Firmenich study documents widespread mycotoxin contamination in global feed ingredients, indicating supply chain quality risks relevant to their animal nutrition business and customer sourcing practices.
DSM-Firmenich study reveals widespread multi-mycotoxin contamination in global feed ingredient supplies, indicating supply chain food safety risks affecting the company's nutrition business.
DSM-Firmenich study reveals widespread mycotoxin contamination in global feed ingredients, indicating supply chain quality and regulatory compliance risks across the company's sourcing operations.
Firmenich's $33M fragrance antitrust settlement presents medium-severity reputational and regulatory risk with potential supply chain compliance implications for DSM-Firmenich's fragrance operations.
DSM-Firmenich's mycotoxin survey highlighting feed contamination prevalence presents medium supply chain risk by addressing food safety quality issues relevant to their animal nutrition and feed ingredient business.
asiabulletin.com: PARSOL Shield Approved by FDA , dsm - firmenich Setting a...; singaporestar.com: PARSOL Shield Approved by FDA , dsm - firmenich Setting a...; philippinetimes.com: PARSOL Shield Approved by FDA , dsm - firmenich Setting a...
GDELTNo issues detected across 2 sources
Top origins: China, India, Indonesia. Period: 2023-09-01 to 2026-09-01
ImportYeti (US Customs)No issues detected across 1 source
Penalties: $900. Quarters non-compliant: 2. Programs: CWA, RCRA
DSM-FIRMENICH: 2 qtrs non-compliance, $900 penalties
EPA ECHORisks tied to the location of this facility.
Political stability: 1.07, Rule of law: 1.76, Corruption control: 2.02
World Bank WGI 2023No issues detected across 2 sources
No issues detected across 3 sources